Drug Search Results
More Filters [+]

Dersalazine

Alternative Names: dersalazine
Latest Update: 2010-11-17
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PAF Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Palau Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dersalazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Colitis, Ulcerative

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CR-IBD-1-08

P2

Completed

Colitis, Ulcerative

2010-06-01

2008-004610-27

P2

Completed

Colitis, Ulcerative

2009-09-02

Recent News Events

Date

Type

Title